Search

Search Results

• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  Published: 6 July 2018

  2467

  PDF: 1273
• 

  Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

  L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi

  224-232

  06-11-2014

  Published: 6 November 2014

  2278

  PDF: 1521

• Long term functional outcome of idiopathic inflammatory myopathies

  R. Neri, M. Mosca, T. Grazzini, A. Tavoni, G. Pasero, S. Bombardieri

  40-45

  Published:

  1032

  PDF: 938
• 

  Histopathology of the muscle in rheumatic diseases

  S. Barsotti, A. Tripoli, L.E. Pollina, M. Mosca, R. Neri

  133-145

  03-10-2018

  Published: 3 October 2018

  1375

  PDF: 1223

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  Published:

  1162

  PDF: 782

• Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre

  C. Baldini, A. Della Rossa, S. Grossi, E. Catarsi, R. Talarico, A. d'Ascanio, M. Mosca, R. Neri, A. Tavoni, S. Bombardieri

  118-124

  Published:

  1520

  PDF: 1471

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  Published:

  1784

  PDF: 1514